NCT01551823View on ClinicalTrials.gov

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug）

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

August 31, 2012

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza Virus Vaccine(no Preservative )

Influenza Virus Vaccine(no Preservative) 2×0.25ml intramuscular injections

BIOLOGICAL

Influenza Virus Vaccine(contains Preservative)

Influenza Virus Vaccine(contains Preservative)2×0.25ml intramuscular injections

Trial Locations (1)

Unknown

Dingxing Center for Disease Prevention and Control, Shijiazhuang

All Listed Sponsors
collaborator

Hebei Center for Disease Control and Prevention

UNKNOWN

lead

Institute of Medical Biology, Chinese Academy of Medical Sciences

OTHER

NCT01551823 - The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug） | Biotech Hunter | Biotech Hunter